Patients Taking Lower Maintenance Doses of Peanut Oral Immunotherapy May Still Achieve Desensitization – Benzinga
MD Magazine |
Patients Taking Lower Maintenance Doses of Peanut Oral Immunotherapy May Still Achieve Desensitization
Benzinga Oral immunotherapy (OIT) is a treatment that could potentially help peanut allergic patients achieve desensitization, but some patients are unable to tolerate maintenance doses that are large enough to facilitate unlimited peanut consumption. When … Desensitization Still Achieved With Long-Term, Low-Dose Peanut OIT |
